Ropinirole

Generic name: Pronounced as (roe pin' i role)
Brand names
  • Requip®
  • Requip® XL
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 02/15/2022

Ropinirole is used alone or with other medications to treat the symptoms of Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance), including shaking of parts of the body, stiffness, slowed movements, and problems with balance. Ropinirole is also used to treat restless legs syndrome (RLS or Ekbom syndrome; a condition that causes discomfort in the legs and a strong urge to move the legs, especially at night and when sitting or lying down). Ropinirole is in a class of medications called dopamine agonists. It works by acting in place of dopamine, a natural substance in the brain that is needed to control movement.

Ropinirole comes as a tablet and an extended-release (long-acting) tablet to take by mouth. Ropinirole may be taken with food to prevent stomach upset. When ropinirole is used to treat Parkinson's disease, the regular tablet is usually taken three times a day and the extended-release tablet is taken once daily. When ropinirole is used to treat restless legs syndrome, the regular tablet is usually taken once a day, 1 to 3 hours before bedtime. Ropinirole extended-release tablets are not used to treat restless legs syndrome. Take ropinirole at around the same time(s) every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take ropinirole exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

There are other medications that have names similar to the brand name for ropinirole. You should be sure that you receive ropinirole and not one of the similar medications each time you fill your prescription. Be sure that the prescription your doctor gives you is clear and easy to read. You should know the name of your medication and why you are taking it. If you think you were given the wrong medication, talk to your pharmacist. Do not take any medication unless you are certain it is the medication that your doctor prescribed.

Swallow the extended-release tablets whole; do not split, chew, or crush them.

Your doctor will start you on a low dose of ropinirole and gradually increase your dose to help control your symptoms. If you are taking ropinirole to treat Parkinson's disease, your doctor will probably not increase your dose more often than once a week. If you are taking ropinirole to treat restless legs syndrome, your doctor will probably increase your dose after 2 days, again at the end of the first week, and then not more often than once a week. It may take several weeks before you reach a dose that works for you. If you are taking ropinirole to treat restless legs syndrome, you may receive a starter kit that contains tablets of increasing doses to be taken during the first 2 weeks of your treatment. The dose of medication you will need depends on how well your body responds to the medication, and may be different than the doses contained in the kit. Your doctor will tell you how to use the kit and whether you should take all the tablets it contains. Follow your doctor's directions carefully.

Ropinirole controls the symptoms of Parkinson's disease and restless legs syndrome but does not cure these conditions. Continue to take ropinirole even if you feel well. Do not stop taking ropinirole without talking to your doctor. If you are taking ropinirole and you suddenly stop taking the medication, you may experience fever, muscle stiffness, sweating, confusion, pain, a lack of interest or concern for usual activities or things you usually care about, anxiety, depression, tiredness, difficulty falling asleep or staying asleep, and other symptoms. If your doctor asks you to stop taking ropinirole, your doctor will probably decrease your dose gradually, over 7 days.

If you stop taking ropinirole for any reason, do not start to take the medication again without talking to your doctor. Your doctor will probably want to increase your dose again gradually.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking ropinirole,

  • tell your doctor and pharmacist if you are allergic to ropinirole, any other medications, or any of the ingredients in ropinirole tablets or extended-release tablets. Ask your doctor or pharmacist for a list of ingredients in ropinirole regular or extended-release tablets.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: antidepressants ('mood elevators'); antipsychotics (medications for mental illness); cimetidine (Tagamet, Tagamet HB); fluoroquinolone antibiotics such as ciprofloxacin (Cipro), and norfloxacin (Noroxin); fluvoxamine (Luvox); hormone replacement therapy and hormonal contraceptives (birth control pill, patches, rings, and injections); insulin; lansoprazole (Prevacid); levodopa (in Sinemet, in Stalevo); medications for anxiety and seizures; medications that cause drowsiness; metoclopramide (Reglan); mexiletine (Mexitil); modafanil (Provigil); nafcillin; omeprazole (Prilosec, Zegerid); sedatives; sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Be sure to tell your doctor or pharmacist if you stop taking any medications while you are taking ropinirole.

  • tell your doctor if you have ever had an urge to gamble that was difficult to control and if you have or have ever had unexpected daytime sleepiness or a sleep disorder other than restless legs syndrome; high or low blood pressure; a psychotic disorder (mental illness that causes abnormal thinking or perceptions); or heart, liver, or kidney disease.

  • tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking ropinirole, call your doctor. Also tell your doctor if you are breast-feeding. Ropinirole may decrease the amount of your breast milk.

  • you should know that ropinirole may make you drowsy or may cause you to suddenly fall asleep during your regular daily activities. You might not feel drowsy or have any other warning signs before you suddenly fall asleep. Do not drive a car, operate machinery, work at heights, or participate in potentially dangerous activities at the beginning of your treatment until you know how the medication affects you. If you suddenly fall asleep while you are doing something such as watching television, talking, eating, or riding in a car, or if you become very drowsy, especially during the daytime, call your doctor. Do not drive, work in high places, or operate machinery until you talk to your doctor.

  • remember that alcohol can add to the drowsiness caused by this medication. Tell your doctor if you regularly drink alcoholic drinks.

  • tell your doctor if you use tobacco products. Call your doctor if you start or stop smoking during your treatment with ropinirole. Smoking may decrease the effectiveness of this medication.

  • you should know that some people who took or used medications such as ropinirole developed intense urges or behaviors that were compulsive or unusual for them, such as gambling, increased sexual urges or behaviors, excessive shopping, and binge eating. Call your doctor if you have an urge to gamble that is difficult to control, you have intense urges to shop, eat, have sex, or gamble, or you are unable to control your behavior. Tell your family members about this risk so that they can call the doctor even if you do not realize that your gambling or any other intense urges or unusual behaviors have become a problem.

  • you should know that ropinirole may cause dizziness, lightheadedness, nausea, or sweating when you get up too quickly from a sitting or lying position. This is more common when you first start taking ropinirole or with an increase in the dose of ropinirole. To avoid this problem, get out of the chair or bed slowly, resting your feet on the floor for a few minutes before standing up.

Unless your doctor tells you otherwise, continue your normal diet.

If you are taking regular ropinirole tablets to treat Parkinson's disease and you miss a dose, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule.

If you are taking regular ropinirole tablets to treat restless legs syndrome and you miss a dose, skip the missed dose. Take your regular dose 1 to 3 hours before your next bedtime. Do not double the next dose to make up for the missed dose.

If you are taking extended-release ropinirole tablets to treat Parkinson's disease and you miss a dose, take the missed dose as soon as you remember it. Return to your regular dosing schedule the next day. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Ropinirole may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • stomach pain

    • heartburn or gas

    • diarrhea

    • constipation

    • decrease in appetite

    • weight loss

    • dizziness

    • drowsiness

    • tiredness

    • weakness

    • headache

    • sweating or flushing

    • confusion

    • difficulty remembering or concentrating

    • anxiety

    • uncontrolled, sudden body movements

    • shaking of a part of your body that you cannot control

    • decreased sensitivity (response) to touch

    • frequent or urgent need to urinate

    • difficulty urinating or pain when urinating

    • in men, difficulty achieving or maintaining an erection

    • back, muscle, or joint pain

    • pain, burning, numbness, or tingling in the hands or feet

    • swelling of the hands, arms, feet, ankles, or lower legs

    • dry mouth

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

    • hallucinations (seeing things or hearing voices that do not exist)

    • feeling unusually suspicious of others

    • confusion

    • aggressive or unfriendly behavior

    • having strange thoughts or beliefs that have no basis in reality

    • agitation

    • fainting

    • chest pain

    • slow, fast, or irregular heartbeat

    • rash

    • hives

    • itching

    • swelling of the face, lips, mouth, tongue, or throat

    • shortness of breath

    • difficulty swallowing or breathing

    • double vision or other changes in vision

  • Some people taking ropinirole and other similar medications have developed fibrotic changes (scarring or thickening) in their lungs and heart valves. It is not yet known whether this problem is caused by ropinirole. Talk to your doctor about the risk of taking this medication.

  • Ropinirole may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from direct sunlight, excess heat, and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • nausea

  • vomiting

  • dizziness

  • fainting

  • hallucinations (seeing things or hearing voices that do not exist)

  • nightmares

  • drowsiness

  • confusion

  • sweating

  • fear when in a small or closed space

  • body movements that are difficult to control

  • fast, irregular, or pounding heartbeat

  • chest pain

  • weakness

  • cough

  • agitation

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of adverse effects can be increased when Moxifloxacin is combined with Ropinirole.
Montelukast Montelukast The metabolism of Ropinirole can be increased when combined with Montelukast.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The metabolism of Ropinirole can be increased when combined with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Ropinirole can be decreased when it is combined with Leflunomide.
Nevirapine Nevirapine The metabolism of Ropinirole can be decreased when combined with Nevirapine.
Dolasetron Dolasetron Dolasetron may increase the sedative activities of Ropinirole.
Anagrelide Anagrelide The risk or severity of adverse effects can be increased when Anagrelide is combined with Ropinirole.
Candesartan Candesartan Ropinirole may increase the hypotensive activities of Candesartan.
Diphenoxylate Diphenoxylate Diphenoxylate may increase the sedative activities of Ropinirole.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The risk or severity of adverse effects can be increased when Conjugated estrogens is combined with Ropinirole.
Guanfacine Guanfacine Guanfacine may increase the sedative activities of Ropinirole.
Methylergonovine Methylergonovine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Methylergometrine.
Naratriptan Naratriptan Naratriptan may increase the sedative activities of Ropinirole.
Paregoric Paregoric Morphine may increase the sedative activities of Ropinirole.
Penbutolol Penbutolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Acebutolol.
Pentazocine Pentazocine Pentazocine may increase the sedative activities of Ropinirole.
Ranitidine Ranitidine The risk or severity of adverse effects can be increased when Ranitidine is combined with Ropinirole.
Reserpine Reserpine Reserpine may increase the sedative activities of Ropinirole.
Rizatriptan Rizatriptan Rizatriptan may increase the sedative activities of Ropinirole.
Sumatriptan Sumatriptan Sumatriptan may increase the sedative activities of Ropinirole.
Tizanidine Tizanidine Tizanidine may increase the sedative activities of Ropinirole.
Zolmitriptan Zolmitriptan Zolmitriptan may increase the sedative activities of Ropinirole.
Famotidine Injection Famotidine Injection The metabolism of Ropinirole can be decreased when combined with Famotidine.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may increase the sedative activities of Ropinirole.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Ropinirole.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ropinirole.
Levofloxacin Injection Levofloxacin Injection The risk or severity of adverse effects can be increased when Levofloxacin is combined with Ropinirole.
Meperidine Injection Meperidine Injection The metabolism of Ropinirole can be increased when combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The therapeutic efficacy of Ropinirole can be decreased when used in combination with Metoclopramide.
Morphine Injection Morphine Injection Morphine may increase the sedative activities of Ropinirole.
Altretamine Altretamine Amphetamine may increase the sedative activities of Ropinirole.
Ondansetron Ondansetron The risk or severity of adverse effects can be increased when Ondansetron is combined with Ropinirole.
Granisetron Granisetron Granisetron may increase the sedative activities of Ropinirole.
Torsemide Torsemide The risk or severity of adverse effects can be increased when Ropinirole is combined with Torasemide.
Olanzapine Olanzapine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Olanzapine.
Alosetron Alosetron The risk or severity of adverse effects can be increased when Alosetron is combined with Ropinirole.
Entacapone Entacapone Entacapone may increase the sedative activities of Ropinirole.
Eprosartan Eprosartan The risk or severity of adverse effects can be increased when Ropinirole is combined with Eprosartan.
Oxcarbazepine Oxcarbazepine Oxcarbazepine may increase the sedative activities of Ropinirole.
Telmisartan Telmisartan The risk or severity of adverse effects can be increased when Ropinirole is combined with Telmisartan.
Zaleplon Zaleplon Zaleplon may increase the sedative activities of Ropinirole.
Anakinra Anakinra The metabolism of Ropinirole can be increased when combined with Anakinra.
Desloratadine Desloratadine Desloratadine may increase the sedative activities of Ropinirole.
Linezolid Linezolid Linezolid may increase the sedative activities of Ropinirole.
Trimipramine Trimipramine Trimipramine may increase the sedative activities of Ropinirole.
Etanercept Injection Etanercept Injection The metabolism of Ropinirole can be increased when combined with Etanercept.
Glycopyrrolate Glycopyrrolate Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Modafinil Modafinil The metabolism of Ropinirole can be increased when combined with Modafinil.
Perindopril Perindopril The risk or severity of adverse effects can be increased when Ropinirole is combined with Perindopril.
Eplerenone Eplerenone The risk or severity of adverse effects can be increased when Ropinirole is combined with Eplerenone.
Escitalopram Escitalopram Escitalopram may increase the sedative activities of Ropinirole.
Olmesartan Olmesartan The risk or severity of adverse effects can be increased when Ropinirole is combined with Olmesartan.
Zonisamide Zonisamide Zonisamide may increase the sedative activities of Ropinirole.
Adalimumab Injection Adalimumab Injection The metabolism of Ropinirole can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The therapeutic efficacy of Ropinirole can be decreased when used in combination with Aripiprazole.
Atomoxetine Atomoxetine Atomoxetine may increase the sedative activities of Ropinirole.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may increase the sedative activities of Ropinirole.
Almotriptan Almotriptan Almotriptan may increase the sedative activities of Ropinirole.
Eletriptan Eletriptan Eletriptan may increase the sedative activities of Ropinirole.
Vardenafil Vardenafil The risk or severity of hypotension can be increased when Vardenafil is combined with Ropinirole.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The risk or severity of adverse effects can be increased when Interferon beta-1a is combined with Ropinirole.
Tegaserod Tegaserod The risk or severity of adverse effects can be increased when Tegaserod is combined with Ropinirole.
Tadalafil Tadalafil Ropinirole may increase the hypotensive activities of Tadalafil.
Frovatriptan Frovatriptan Frovatriptan may increase the sedative activities of Ropinirole.
Gemifloxacin Gemifloxacin The risk or severity of adverse effects can be increased when Gemifloxacin is combined with Ropinirole.
Apomorphine Injection Apomorphine Injection Ropinirole may increase the sedative activities of Apomorphine.
Infliximab Injection Infliximab Injection The metabolism of Ropinirole can be increased when combined with Infliximab.
Protriptyline Protriptyline Protriptyline may increase the sedative activities of Ropinirole.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Ropinirole is combined with Duloxetine.
Trospium Trospium Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Trospium.
Bosentan Bosentan Ropinirole may increase the hypotensive activities of Bosentan.
Eszopiclone Eszopiclone The risk or severity of CNS depression can be increased when Ropinirole is combined with Eszopiclone.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The metabolism of Ropinirole can be increased when combined with Insulin aspart.
Solifenacin Solifenacin Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the sedative activities of Ropinirole.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Ropinirole.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ropinirole.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the sedative activities of Ropinirole.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the sedative activities of Ropinirole.
Ramelteon Ramelteon Ramelteon may increase the sedative activities of Ropinirole.
Darifenacin Darifenacin Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.
Fentanyl Fentanyl Fentanyl may increase the sedative activities of Ropinirole.
Pregabalin Pregabalin The therapeutic efficacy of Ropinirole can be increased when used in combination with Pregabalin.
Deferasirox Deferasirox The risk or severity of adverse effects can be increased when Deferasirox is combined with Ropinirole.
Phenylephrine Phenylephrine The metabolism of Ropinirole can be increased when combined with Phenylephrine.
Felbamate Felbamate Felbamate may increase the sedative activities of Ropinirole.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The metabolism of Ropinirole can be increased when combined with Insulin detemir.
Abatacept Injection Abatacept Injection The metabolism of Ropinirole can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the sedative activities of Ropinirole.
Paliperidone Paliperidone The therapeutic efficacy of Ropinirole can be decreased when used in combination with Paliperidone.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Clofarabine.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The metabolism of Ropinirole can be increased when combined with Insulin glulisine.
Primaquine Primaquine The metabolism of Ropinirole can be increased when combined with Primaquine.
Aliskiren Aliskiren The risk or severity of adverse effects can be increased when Ropinirole is combined with Aliskiren.
Dimenhydrinate Dimenhydrinate Dimenhydrinate may increase the sedative activities of Ropinirole.
Nabilone Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Ropinirole.
Dronabinol Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ropinirole.
Levocetirizine Levocetirizine Levocetirizine may increase the sedative activities of Ropinirole.
Mexiletine Mexiletine The risk or severity of adverse effects can be increased when Mexiletine is combined with Ropinirole.
Armodafinil Armodafinil The metabolism of Ropinirole can be increased when combined with Armodafinil.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection Botulinum toxin type A may increase the sedative activities of Ropinirole.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection Botulinum Toxin Type B may increase the sedative activities of Ropinirole.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Desvenlafaxine may increase the sedative activities of Ropinirole.
Nebivolol Nebivolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Ropinirole is combined with Tretinoin.
Certolizumab Injection Certolizumab Injection The metabolism of Ropinirole can be increased when combined with Certolizumab pegol.
Rufinamide Rufinamide Rufinamide may increase the sedative activities of Ropinirole.
Midazolam Midazolam Midazolam may increase the sedative activities of Ropinirole.
Milnacipran Milnacipran Milnacipran may increase the sedative activities of Ropinirole.
Fesoterodine Fesoterodine Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.
Betaxolol Betaxolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Betaxolol.
Iloperidone Iloperidone The therapeutic efficacy of Ropinirole can be decreased when used in combination with Iloperidone.
Lacosamide Lacosamide Lacosamide may increase the sedative activities of Ropinirole.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection Botulinum toxin type A may increase the sedative activities of Ropinirole.
Palonosetron Injection Palonosetron Injection Palonosetron may increase the sedative activities of Ropinirole.
Tapentadol Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ropinirole.
Golimumab Injection Golimumab Injection The metabolism of Ropinirole can be increased when combined with Golimumab.
Asenapine Asenapine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Asenapine.
Vigabatrin Vigabatrin Vigabatrin may increase the sedative activities of Ropinirole.
Albendazole Albendazole The metabolism of Ropinirole can be increased when combined with Albendazole.
Oxymorphone Oxymorphone Oxymorphone may increase the sedative activities of Ropinirole.
Tocilizumab Injection Tocilizumab Injection The metabolism of Ropinirole can be increased when combined with Tocilizumab.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection Botulinum toxin type A may increase the sedative activities of Ropinirole.
Lurasidone Lurasidone The therapeutic efficacy of Ropinirole can be decreased when used in combination with Lurasidone.
Vilazodone Vilazodone Vilazodone may increase the sedative activities of Ropinirole.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ropinirole.
Azilsartan Azilsartan The risk or severity of adverse effects can be increased when Ropinirole is combined with Azilsartan medoxomil.
Telaprevir Telaprevir The risk or severity of adverse effects can be increased when Glecaprevir is combined with Ropinirole.
Abiraterone Abiraterone The risk or severity of adverse effects can be increased when Abiraterone is combined with Ropinirole.
Clobazam Clobazam Clobazam may increase the sedative activities of Ropinirole.
Vemurafenib Vemurafenib The serum concentration of Ropinirole can be increased when it is combined with Vemurafenib.
Cabergoline Cabergoline Cabergoline may increase the sedative activities of Ropinirole.
Ambrisentan Ambrisentan Ropinirole may increase the hypotensive activities of Ambrisentan.
Ezogabine Ezogabine Tiagabine may increase the sedative activities of Ropinirole.
Iloprost Iloprost The risk or severity of adverse effects can be increased when Ropinirole is combined with Iloprost.
Teriflunomide Teriflunomide The metabolism of Ropinirole can be increased when combined with Teriflunomide.
Pomalidomide Pomalidomide Pomalidomide may increase the sedative activities of Ropinirole.
Canagliflozin Canagliflozin The risk or severity of adverse effects can be increased when Ropinirole is combined with Canagliflozin.
Methazolamide Methazolamide The risk or severity of adverse effects can be increased when Ropinirole is combined with Methazolamide.
Levomilnacipran Levomilnacipran Levomilnacipran may increase the sedative activities of Ropinirole.
Vortioxetine Vortioxetine Vortioxetine may increase the sedative activities of Ropinirole.
Perampanel Perampanel Perampanel may increase the sedative activities of Ropinirole.
Avanafil Avanafil The risk or severity of hypotension can be increased when Avanafil is combined with Ropinirole.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Obinutuzumab.
Simeprevir Simeprevir The risk or severity of adverse effects can be increased when Simeprevir is combined with Ropinirole.
Dapagliflozin Dapagliflozin The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Ropinirole.
Apremilast Apremilast The metabolism of Ropinirole can be increased when combined with Apremilast.
Siltuximab Injection Siltuximab Injection The metabolism of Ropinirole can be increased when combined with Siltuximab.
Eslicarbazepine Eslicarbazepine Eslicarbazepine may increase the sedative activities of Ropinirole.
Belinostat Injection Belinostat Injection The metabolism of Ropinirole can be increased when combined with Belinostat.
Empagliflozin Empagliflozin The risk or severity of adverse effects can be increased when Ropinirole is combined with Empagliflozin.
Hydrocodone Hydrocodone Hydrocodone may increase the central nervous system depressant (CNS depressant) activities of Ropinirole.
Suvorexant Suvorexant Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Ropinirole.
Methamphetamine Methamphetamine Metamfetamine may increase the sedative activities of Ropinirole.
Tasimelteon Tasimelteon Tasimelteon may increase the sedative activities of Ropinirole.
Riociguat Riociguat The risk or severity of adverse effects can be increased when Ropinirole is combined with Riociguat.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Pirfenidone is combined with Ropinirole.
Secukinumab Injection Secukinumab Injection The metabolism of Ropinirole can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The therapeutic efficacy of Ropinirole can be decreased when used in combination with Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The metabolism of Ropinirole can be increased when combined with Insulin human.
Lenvatinib Lenvatinib The risk or severity of adverse effects can be increased when Lenvatinib is combined with Ropinirole.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The therapeutic efficacy of Ropinirole can be decreased when used in combination with Haloperidol.
Amiloride Amiloride The risk or severity of adverse effects can be increased when Ropinirole is combined with Amiloride.
Macitentan Macitentan Ropinirole may increase the hypotensive activities of Macitentan.
Flibanserin Flibanserin Flibanserin may increase the sedative activities of Ropinirole.
Brexpiprazole Brexpiprazole Ropinirole may increase the sedative activities of Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The therapeutic efficacy of Ropinirole can be decreased when used in combination with Ziprasidone.
Cariprazine Cariprazine Cariprazine may increase the sedative activities of Ropinirole.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The metabolism of Ropinirole can be increased when combined with Insulin degludec.
Osimertinib Osimertinib The metabolism of Ropinirole can be increased when combined with Osimertinib.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Amphotericin B.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may increase the sedative activities of Ropinirole.
Selexipag Selexipag Ropinirole may increase the hypotensive activities of Selexipag.
Pimavanserin Pimavanserin Pimavanserin may increase the sedative activities of Ropinirole.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Ropinirole.
Diphenhydramine Injection Diphenhydramine Injection Diphenhydramine may increase the sedative activities of Ropinirole.
Furosemide Injection Furosemide Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Furosemide.
Rucaparib Rucaparib The risk or severity of adverse effects can be increased when Rucaparib is combined with Ropinirole.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may increase the sedative activities of Ropinirole.
Safinamide Safinamide The risk or severity of adverse effects can be increased when Safinamide is combined with Ropinirole.
Midostaurin Midostaurin The risk or severity of adverse effects can be increased when Midostaurin is combined with Ropinirole.
Enasidenib Enasidenib The risk or severity of adverse effects can be increased when Enasidenib is combined with Ropinirole.
Buprenorphine Injection Buprenorphine Injection Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Fostamatinib Fostamatinib The risk or severity of hypotension can be increased when Fostamatinib is combined with Ropinirole.
Lofexidine Lofexidine The therapeutic efficacy of Ropinirole can be increased when used in combination with Lofexidine.
Cannabidiol Cannabidiol Cannabidiol may increase the sedative activities of Ropinirole.
Stiripentol Stiripentol The risk or severity of adverse effects can be increased when Stiripentol is combined with Ropinirole.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Paclitaxel.
Rifamycin Rifamycin The risk or severity of adverse effects can be increased when Rifamycin is combined with Ropinirole.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Ropinirole can be increased when combined with Emapalumab.
Brexanolone Injection Brexanolone Injection Brexanolone may increase the sedative activities of Ropinirole.
Solriamfetol Solriamfetol Solriamfetol may increase the sedative activities of Ropinirole.
Triclabendazole Triclabendazole The risk or severity of adverse effects can be increased when Triclabendazole is combined with Ropinirole.
Pitolisant Pitolisant The metabolism of Ropinirole can be increased when combined with Pitolisant.
Phenytoin Injection Phenytoin Injection The metabolism of Ropinirole can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Ropinirole can be increased when combined with Fosphenytoin.
Lumateperone Lumateperone The therapeutic efficacy of Ropinirole can be decreased when used in combination with Lumateperone.
Lasmiditan Lasmiditan The risk or severity of adverse effects can be increased when Lasmiditan is combined with Ropinirole.
Capmatinib Capmatinib The risk or severity of adverse effects can be increased when Capmatinib is combined with Ropinirole.
Lemborexant Lemborexant Lemborexant may increase the sedative activities of Ropinirole.
Fenfluramine Fenfluramine Fenfluramine may increase the sedative activities of Ropinirole.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Ropinirole can be decreased when it is combined with Satralizumab.
Viloxazine Viloxazine The risk or severity of adverse effects can be increased when Viloxazine is combined with Ropinirole.
Trazodone Trazodone Trazodone may increase the sedative activities of Ropinirole.
Phenobarbital Phenobarbital The metabolism of Ropinirole can be increased when combined with Phenobarbital.
Metaxalone Metaxalone Metaxalone may increase the sedative activities of Ropinirole.
Levorphanol Levorphanol Levorphanol may increase the sedative activities of Ropinirole.
Primidone Primidone The metabolism of Ropinirole can be increased when combined with Primidone.
Methsuximide Methsuximide Methsuximide may increase the sedative activities of Ropinirole.
Diethylpropion Diethylpropion Diethylpropion may increase the sedative activities of Ropinirole.
Chlorpromazine Chlorpromazine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Chlorpromazine.
Diazepam Diazepam Diazepam may increase the sedative activities of Ropinirole.
Oxazepam Oxazepam Oxazepam may increase the sedative activities of Ropinirole.
Flurazepam Flurazepam Flurazepam may increase the sedative activities of Ropinirole.
Clorazepate Clorazepate Clorazepic acid may increase the sedative activities of Ropinirole.
Lorazepam Lorazepam Lorazepam may increase the sedative activities of Ropinirole.
Phenoxybenzamine Phenoxybenzamine The risk or severity of adverse effects can be increased when Ropinirole is combined with Phenoxybenzamine.
Codeine Codeine Codeine may increase the sedative activities of Ropinirole.
Meprobamate Meprobamate Meprobamate may increase the sedative activities of Ropinirole.
Chlordiazepoxide Chlordiazepoxide Chlordiazepoxide may increase the sedative activities of Ropinirole.
Bromocriptine Bromocriptine Ropinirole may increase the sedative activities of Bromocriptine.
Tranylcypromine Tranylcypromine The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Ropinirole.
Phenelzine Phenelzine Phenelzine may increase the sedative activities of Ropinirole.
Procarbazine Procarbazine Procarbazine may increase the sedative activities of Ropinirole.
Ergoloid Mesylates Ergoloid Mesylates Ropinirole may increase the sedative activities of Ergoloid mesylate.
Minocycline Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Ropinirole.
Prochlorperazine Prochlorperazine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Prochlorperazine.
Thioridazine Thioridazine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Thioridazine.
Trifluoperazine Trifluoperazine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Trifluoperazine.
Oxycodone Oxycodone Oxycodone may increase the sedative activities of Ropinirole.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Ropinirole.
Oxybutynin Oxybutynin Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Benztropine Benztropine Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.
Maprotiline Maprotiline Maprotiline may increase the sedative activities of Ropinirole.
Trihexyphenidyl Trihexyphenidyl Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.
Orphenadrine Orphenadrine The risk or severity of adverse effects can be increased when Orphenadrine is combined with Ropinirole.
Perphenazine Perphenazine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Perphenazine.
Fluphenazine Fluphenazine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Fluphenazine.
Methylphenidate Methylphenidate The risk or severity of adverse effects can be increased when Methylphenidate is combined with Ropinirole.
Amoxapine Amoxapine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Amoxapine.
Carbamazepine Carbamazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ropinirole.
Molindone Molindone The therapeutic efficacy of Ropinirole can be decreased when used in combination with Molindone.
Methyldopa Methyldopa The risk or severity of adverse effects can be increased when Ropinirole is combined with Methyldopa.
Clonidine Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Ropinirole.
Prazosin Prazosin The risk or severity of adverse effects can be increased when Ropinirole is combined with Prazosin.
Hydralazine Hydralazine The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydralazine.
Cimetidine Cimetidine The risk or severity of adverse effects can be increased when Cimetidine is combined with Ropinirole.
Warfarin Warfarin The risk or severity of adverse effects can be increased when Ropinirole is combined with Warfarin.
Clonazepam Clonazepam Clonazepam may increase the sedative activities of Ropinirole.
Promethazine Promethazine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Promethazine.
Griseofulvin Griseofulvin The metabolism of Ropinirole can be increased when combined with Griseofulvin.
Loxapine Loxapine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Loxapine.
Quinine Quinine Quinine may increase the sedative activities of Ropinirole.
Ethosuximide Ethosuximide Ethosuximide may increase the sedative activities of Ropinirole.
Triamterene Triamterene The risk or severity of adverse effects can be increased when Ropinirole is combined with Triamterene.
Chlorothiazide Chlorothiazide The risk or severity of adverse effects can be increased when Ropinirole is combined with Chlorothiazide.
Chlorthalidone Chlorthalidone The risk or severity of adverse effects can be increased when Ropinirole is combined with Chlorthalidone.
Metolazone Metolazone The risk or severity of adverse effects can be increased when Ropinirole is combined with Metolazone.
Secobarbital Secobarbital The metabolism of Ropinirole can be increased when combined with Secobarbital.
Desipramine Desipramine Desipramine may increase the sedative activities of Ropinirole.
Amitriptyline Amitriptyline Amitriptyline may increase the sedative activities of Ropinirole.
Imipramine Imipramine The risk or severity of adverse effects can be increased when Imipramine is combined with Ropinirole.
Quinidine Quinidine The risk or severity of adverse effects can be increased when Quinidine is combined with Ropinirole.
Isoniazid Isoniazid The risk or severity of adverse effects can be increased when Isoniazid is combined with Ropinirole.
Rifampin Rifampin The metabolism of Ropinirole can be increased when combined with Rifampicin.
Disopyramide Disopyramide Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.
Valproic Acid Valproic Acid The risk or severity of adverse effects can be increased when Valproic acid is combined with Ropinirole.
Butabarbital Butabarbital Butabarbital may increase the sedative activities of Ropinirole.
Methimazole Methimazole The risk or severity of adverse effects can be increased when Methimazole is combined with Ropinirole.
Dextromethorphan Dextromethorphan Dextromethorphan may increase the sedative activities of Ropinirole.
Cyclobenzaprine Cyclobenzaprine The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Ropinirole.
Baclofen Baclofen Baclofen may increase the sedative activities of Ropinirole.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ropinirole.
Cyproheptadine Cyproheptadine Cyproheptadine may increase the sedative activities of Ropinirole.
Clemastine Clemastine Clemastine may increase the sedative activities of Ropinirole.
Chlorpheniramine Chlorpheniramine Chlorpheniramine may increase the sedative activities of Ropinirole.
Brompheniramine Brompheniramine Dexbrompheniramine may increase the sedative activities of Ropinirole.
Meclizine Meclizine Meclizine may increase the sedative activities of Ropinirole.
Methyclothiazide Methyclothiazide The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Ropinirole.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of adverse effects can be increased when Ropinirole is combined with Hydrochlorothiazide.
Dantrolene Dantrolene Dantrolene may increase the sedative activities of Ropinirole.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may increase the sedative activities of Ropinirole.
Carisoprodol Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ropinirole.
Methocarbamol Methocarbamol Methocarbamol may increase the sedative activities of Ropinirole.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of adverse effects can be increased when Ropinirole is combined with Propranolol.
Minoxidil Minoxidil The risk or severity of adverse effects can be increased when Ropinirole is combined with Minoxidil.
Nortriptyline Nortriptyline Nortriptyline may increase the sedative activities of Ropinirole.
Spironolactone Spironolactone The risk or severity of adverse effects can be increased when Ropinirole is combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Amphotericin B.
Nadolol Nadolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Nadolol.
Butorphanol Injection Butorphanol Injection Butorphanol may increase the sedative activities of Ropinirole.
Nalbuphine Injection Nalbuphine Injection Nalbuphine may increase the sedative activities of Ropinirole.
Trimethobenzamide Trimethobenzamide Trimethobenzamide may increase the sedative activities of Ropinirole.
Flavoxate Flavoxate Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Papaverine Papaverine The risk or severity of adverse effects can be increased when Ropinirole is combined with Papaverine.
Acetazolamide Acetazolamide Acetazolamide may increase the sedative activities of Ropinirole.
Ketoconazole Ketoconazole The risk or severity of adverse effects can be increased when Ketoconazole is combined with Ropinirole.
Pyrantel Pyrantel Pyrantel may increase the sedative activities of Ropinirole.
Captopril Captopril The risk or severity of adverse effects can be increased when Ropinirole is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of adverse effects can be increased when Ropinirole is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of adverse effects can be increased when Ropinirole is combined with Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid The risk or severity of adverse effects can be increased when Ropinirole is combined with Etacrynic acid.
Metoprolol Metoprolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Metoprolol.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ropinirole.
Thiothixene Thiothixene The therapeutic efficacy of Ropinirole can be decreased when used in combination with Thiothixene.
Alprazolam Alprazolam Alprazolam may increase the sedative activities of Ropinirole.
Temazepam Temazepam Temazepam may increase the sedative activities of Ropinirole.
Triazolam Triazolam Triazolam may increase the sedative activities of Ropinirole.
Dicyclomine Dicyclomine Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.
Propantheline Propantheline Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Propantheline.
Diltiazem Diltiazem The risk or severity of adverse effects can be increased when Ropinirole is combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of adverse effects can be increased when Ropinirole is combined with Nifedipine.
Timolol Timolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Timolol.
Verapamil Verapamil The risk or severity of adverse effects can be increased when Ropinirole is combined with Verapamil.
Atenolol Atenolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Atenolol.
Pindolol Pindolol Pindolol may increase the sedative activities of Ropinirole.
Bumetanide Bumetanide The risk or severity of adverse effects can be increased when Ropinirole is combined with Bumetanide.
Streptozocin Streptozocin The metabolism of Ropinirole can be increased when combined with Streptozocin.
Indapamide Indapamide The risk or severity of adverse effects can be increased when Ropinirole is combined with Indapamide.
Nafcillin Injection Nafcillin Injection The metabolism of Ropinirole can be increased when combined with Nafcillin.
Pentoxifylline Pentoxifylline The risk or severity of hypotension can be increased when Pentoxifylline is combined with Ropinirole.
Labetalol Labetalol The risk or severity of adverse effects can be increased when Ropinirole is combined with Labetalol.
Gemfibrozil Gemfibrozil The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Ropinirole.
Guanabenz Guanabenz Ropinirole may increase the hypotensive activities of Guanabenz.
Pimozide Pimozide The therapeutic efficacy of Ropinirole can be decreased when used in combination with Pimozide.
Enalapril Enalapril The risk or severity of adverse effects can be increased when Ropinirole is combined with Enalapril.
Amiodarone Amiodarone The risk or severity of adverse effects can be increased when Amiodarone is combined with Ropinirole.
Buspirone Buspirone The therapeutic efficacy of Ropinirole can be decreased when used in combination with Buspirone.
Ciprofloxacin Ciprofloxacin The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Ropinirole.
Fluoxetine Fluoxetine The risk or severity of adverse effects can be increased when Fluoxetine is combined with Ropinirole.
Nimodipine Nimodipine The risk or severity of adverse effects can be increased when Ropinirole is combined with Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Ropinirole.
Clozapine Clozapine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Clozapine.
Estazolam Estazolam Estazolam may increase the sedative activities of Ropinirole.
Ofloxacin Ofloxacin The risk or severity of adverse effects can be increased when Ofloxacin is combined with Ropinirole.
Benazepril Benazepril The risk or severity of adverse effects can be increased when Ropinirole is combined with Benazepril.
Felodipine Felodipine The risk or severity of adverse effects can be increased when Ropinirole is combined with Felodipine.
Fosinopril Fosinopril The risk or severity of adverse effects can be increased when Ropinirole is combined with Fosinopril.
Quinapril Quinapril The risk or severity of adverse effects can be increased when Ropinirole is combined with Quinapril.
Ramipril Ramipril The risk or severity of adverse effects can be increased when Ropinirole is combined with Ramipril.
Amlodipine Amlodipine The risk or severity of adverse effects can be increased when Ropinirole is combined with Amlodipine.
Lisinopril Lisinopril The risk or severity of adverse effects can be increased when Ropinirole is combined with Lisinopril.
Sotalol Sotalol The risk or severity of adverse effects can be increased when Ropinirole is combined with Sotalol.
Bisoprolol Bisoprolol The risk or severity of adverse effects can be increased when Ropinirole is combined with Bisoprolol.
Zolpidem Zolpidem Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Doxazosin Doxazosin The risk or severity of adverse effects can be increased when Ropinirole is combined with Doxazosin.
Terazosin Terazosin The risk or severity of adverse effects can be increased when Ropinirole is combined with Terazosin.
Isradipine Isradipine The risk or severity of adverse effects can be increased when Ropinirole is combined with Isradipine.
Omeprazole Omeprazole The risk or severity of adverse effects can be increased when Omeprazole is combined with Ropinirole.
Cisapride Cisapride Cisapride may increase the sedative activities of Ropinirole.
Gabapentin Gabapentin Gabapentin may increase the sedative activities of Ropinirole.
Venlafaxine Venlafaxine Venlafaxine may increase the sedative activities of Ropinirole.
Fluvoxamine Fluvoxamine The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Ropinirole.
Nefazodone Nefazodone Nefazodone may increase the sedative activities of Ropinirole.
Lamotrigine Lamotrigine Lamotrigine may increase the sedative activities of Ropinirole.
Losartan Losartan The risk or severity of adverse effects can be increased when Ropinirole is combined with Losartan.
Tramadol Tramadol The risk or severity of CNS depression can be increased when Tramadol is combined with Ropinirole.
Moexipril Moexipril The risk or severity of adverse effects can be increased when Ropinirole is combined with Moexipril.
Nicardipine Nicardipine Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.
Bupropion Bupropion The risk or severity of adverse effects can be increased when Bupropion is combined with Ropinirole.
Ticlopidine Ticlopidine The risk or severity of adverse effects can be increased when Ticlopidine is combined with Ropinirole.
Nisoldipine Nisoldipine The risk or severity of adverse effects can be increased when Ropinirole is combined with Nisoldipine.
Riluzole Riluzole Riluzole may increase the sedative activities of Ropinirole.
Amifostine Injection Amifostine Injection The risk or severity of adverse effects can be increased when Ropinirole is combined with Amifostine.
Ritonavir Ritonavir The metabolism of Ropinirole can be increased when combined with Ritonavir.
Clomipramine Clomipramine Clomipramine may increase the sedative activities of Ropinirole.
Zafirlukast Zafirlukast The risk or severity of adverse effects can be increased when Zafirlukast is combined with Ropinirole.
Mirtazapine Mirtazapine Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Trandolapril Trandolapril The risk or severity of adverse effects can be increased when Ropinirole is combined with Trandolapril.
Topiramate Topiramate Topiramate may increase the sedative activities of Ropinirole.
Valsartan Valsartan The risk or severity of adverse effects can be increased when Ropinirole is combined with Valsartan.
Insulin Lispro Injection Insulin Lispro Injection The metabolism of Ropinirole can be increased when combined with Insulin lispro.
Pramipexole Pramipexole Ropinirole may increase the sedative activities of Pramipexole.
Donepezil Donepezil Donepezil may increase the sedative activities of Ropinirole.
Carvedilol Carvedilol The risk or severity of adverse effects can be increased when Ropinirole is combined with Carvedilol.
Selegiline Selegiline The risk or severity of adverse effects can be increased when Selegiline is combined with Ropinirole.
Sertraline Sertraline Sertraline may increase the sedative activities of Ropinirole.
Propafenone Propafenone The risk or severity of adverse effects can be increased when Propafenone is combined with Ropinirole.
Irbesartan Irbesartan The risk or severity of adverse effects can be increased when Ropinirole is combined with Irbesartan.
Tamsulosin Tamsulosin The risk or severity of adverse effects can be increased when Ropinirole is combined with Tamsulosin.
Quetiapine Quetiapine The therapeutic efficacy of Ropinirole can be decreased when used in combination with Quetiapine.
Cetirizine Cetirizine Cetirizine may increase the sedative activities of Ropinirole.
Paroxetine Paroxetine Paroxetine may increase the sedative activities of Ropinirole.
Tolcapone Tolcapone Tolcapone may increase the sedative activities of Ropinirole.
Citalopram Citalopram The risk or severity of adverse effects can be increased when Citalopram is combined with Ropinirole.
Efavirenz Efavirenz The risk or severity of adverse effects can be increased when Efavirenz is combined with Ropinirole.
Sildenafil Sildenafil The risk or severity of hypotension can be increased when Sildenafil is combined with Ropinirole.
Rosiglitazone Rosiglitazone The risk or severity of adverse effects can be increased when Rosiglitazone is combined with Ropinirole.
Tolterodine Tolterodine Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.
Thalidomide Thalidomide Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Levetiracetam Levetiracetam Levetiracetam may increase the sedative activities of Ropinirole.
Rabeprazole Rabeprazole The metabolism of Ropinirole can be increased when combined with Rabeprazole.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists